Refractory Ascites Clinical Trial
Official title:
The Use of Midodrine, Octreotide and Albumin in Refractory Ascites
We will address the hypothesis that refractory ascites and Type 2 hepatorenal syndrome are
mediated in part by diminished circulatory volume and that treatment with midodrine,
octreotide and albumin can improve renal and patient outcomes by restoring effective
circulating volume and systemic perfusion.
Our primary objective is to assess change in creatinine clearance using inulin. We will
enroll 15 patients with Type 2 hepatorenal syndrome or refractory ascites once inclusion and
exclusion criteria are satisfied. They will be treated for 1 month with octreotide LAR,
albumin and midodrine. Renal, serum and neurohormonal parameters will be measured before,
during, and after initiation of drug and compared.
n/a
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04050683 -
Evaluation of Hemodynamic Parameters Following Transjugular Intrahepatic Portosystemic Shunt (TIPS)
|
N/A | |
| Active, not recruiting |
NCT01438970 -
Effects of Treatment of Ascites by the ALFApump System on Renal and Circulatory Function
|
Phase 2 | |
| Not yet recruiting |
NCT04621617 -
Midodrine and Albumin in Patients With Refractory Ascites
|
Phase 3 | |
| Recruiting |
NCT05700708 -
Point-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function, Renal and Cardiac Biomarkers in Cirrhosis With Refractory Ascites
|
||
| Terminated |
NCT02026609 -
Glutamine Challenge as Predictor of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS)
|
N/A | |
| Recruiting |
NCT01558895 -
Infrared Ray Heat Treatment in Liver Cirrhosis Patients With Refractory Ascites
|
Phase 2/Phase 3 | |
| Recruiting |
NCT04043858 -
Safety and Efficacy of Midodrine Hydrochloride in the Management of Refractory Ascites Due to Cirrhosis in Children
|
N/A | |
| Completed |
NCT01532427 -
ALFApump System Post Marketing Surveillance Registry
|
||
| Completed |
NCT01440829 -
The Effectiveness of L-ornithine-L-aspartate (LOLA) on Plasma Ammonia in Cirrhotic Patients After TIPS
|
Phase 2/Phase 3 | |
| Completed |
NCT00870662 -
A Feasibility Study of the Automated Fluid Shunt (AFS) for Automated Ascites Removal
|
N/A | |
| Active, not recruiting |
NCT05434286 -
Point-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function, Renal and Cardiac Biomarkers in Cirrhosis With Hepatorenal Syndrome-Acute Kidney Injury
|
||
| Completed |
NCT06196723 -
Early Transjugular Intrahepatic Portosystemic Shunts Improve Survival in Patients With Cirrhosis and Recurrent Ascites
|